Fibroblast growth factor receptor 3 isoforms: Novel therapeutic targets for hepatocellular carcinoma?

Author:

Paur Jakob1,Nika Lisa1,Maier Christiane1,Moscu-Gregor Alexander1,Kostka Julia1,Huber Daniela1,Mohr Thomas1,Heffeter Petra1,Schrottmaier Waltraud C.1,Kappel Sonja2,Kandioler Daniela2,Holzmann Klaus1,Marian Brigitte1,Berger Walter1,Grusch Michael1,Grasl-Kraupp Bettina1

Affiliation:

1. Department of Medicine I, Division: Institute of Cancer Research, Comprehensive Cancer Center Vienna; Medical University of Vienna; Vienna Austria

2. Department of Surgery; Medical University of Vienna; Vienna Austria

Funder

The FWF

Publisher

Wiley

Subject

Hepatology

Reference45 articles.

1. Globocan: estimated cancer incidence, mortality and prevalence worldwide in 2012 2012 http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx http://www.iarc.fr/

2. Hepatocellular carcinoma;Forner;Lancet,2012

3. HCC therapies: lessons learned;Wörns;Nat Rev Gastroenterol Hepatol,2014

4. Deregulation of signaling pathways in prognostic subtypes of hepatocellular carcinoma;Calvisi;Biochim Biophys Acta,2012

5. Up-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis;Gauglhofer;Hepatology,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3